Targeting NRF2 to suppress ferroptosis in brain injury

• Shunchen Song ^[1] ; Yaxuan Gao ^[1] ; Yi Sheng ^[1] ; Tongyu Rui ^[1] ; Chengliang Luo ^[1]
  1. [1] Soochow University

     Soochow University

     China

     
• Localización: Histology and histopathology: cellular and molecular biology, ISSN-e 1699-5848, ISSN 0213-3911, Vol. 36, Nº. 4, 2021, págs. 383-397
• Idioma: inglés
• Enlaces
  • Texto completo
• Resumen

  • Brain injury is accompanied by serious iron metabolism disorder and oxidative stress. As a novel form of regulated cell death (RCD) depending on lipid peroxidation caused by iron overload, ferroptosis (FPT) further aggravates brain injury, which is different from apoptosis, autophagy and other traditional cell death in terms of biochemistry, morphology and genetics.

    Noteworthy, transcriptional regulator NRF2 plays a key role in the cell antioxidant system, and many genes related to FPT are under the control of NRF2, including genes for iron regulation, thiol-dependent antioxidant system, enzymatic detoxification of RCS and carbonyls, NADPH regeneration and ROS sources from mitochondria or extra-mitochondria, which place NRF2 in the key position of regulating the ferroptotic death.

    Importantly, NRF2 can reduce iron load and resist FPT.

    In the future, it is expected to open up a new way to treat brain injury by targeting NRF2 to alleviate FPT in brain.